To assess the importance patients place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience), and how these patients’ views differ depending on the stage of their therapy (pretreatment, preoperative therapy, post-operative, long-term surveillance, recurrence).

PRIMARY OBJECTIVE:

I. To assess the importance patients place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience).

SECONDARY OBJECTIVES:

I. To assess which attributes of value (i.e., outcomes, QOL, cost, experience) health care providers (i.e., physicians, nurses, administrators) feel are most important in health care delivery.

II. To assess how these patients' views differ depending on the stage of their therapy (pretreatment, preoperative therapy, post-operative, long-term surveillance, recurrence).

III. To assess how patients' view differ to health providers.

OUTLINE:

Patients and healthcare providers complete a survey over 10-15 minutes.

Inclusion Criteria:

• Any patient who has been treated, or is anticipated to be treated, for potentially resectable, biopsy-proven pancreatic adenocarcinoma, pancreatic neuroendocrine malignancy, or gastric adenocarcinoma
• Providers involved in the care of gastric and pancreatic cancer patients. Providers will include non-collaborative surgical oncologists, medical oncologists, radiation oncologists, administrators, nurses, mid-level providers
• Able to understand the description of the study and willing to participate

Exclusion Criteria:

• Inability to read and answer questions in English

Patients with pancreatic adenocarcinoma, pancreatic neuroendocrine malignancy, or gastric adenocarcinoma, and healthcare providers involved in the care of gastric and pancreatic cancer patients at the MD Anderson Cancer Center